Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

References for PMC Articles for PubMed (Select 21319341)

1.

[The role of adipose tissue and macrophages in chronic inflammation associated with obesity: clinical implications].

Ramalho R, Guimarães C.

Acta Med Port. 2008 Sep-Oct;21(5):489-96. Epub 2009 Jan 16. Review. Portuguese.

2.

Body-mass index and mortality in Korean men and women.

Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, Samet JM.

N Engl J Med. 2006 Aug 24;355(8):779-87. Epub 2006 Aug 22.

3.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

PMID:
16613757
4.

Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake.

Kasim-Karakas SE, Tsodikov A, Singh U, Jialal I.

Am J Clin Nutr. 2006 Apr;83(4):774-9.

5.

Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss.

Manigrasso MR, Ferroni P, Santilli F, Taraborelli T, Guagnano MT, Michetti N, Davì G.

J Clin Endocrinol Metab. 2005 Oct;90(10):5876-9. Epub 2005 Jul 19.

PMID:
16030165
6.
7.

A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity.

Seshadri P, Iqbal N, Stern L, Williams M, Chicano KL, Daily DA, McGrory J, Gracely EJ, Rader DJ, Samaha FF.

Am J Med. 2004 Sep 15;117(6):398-405. Erratum in: Am J Med. 2006 Feb;119(2):191.

PMID:
15380496
8.

The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial.

Caballero AE, Delgado A, Aguilar-Salinas CA, Herrera AN, Castillo JL, Cabrera T, Gomez-Perez FJ, Rull JA.

J Clin Endocrinol Metab. 2004 Aug;89(8):3943-8.

PMID:
15292331
10.

Evidence for a potent antiinflammatory effect of rosiglitazone.

Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T, Al-Haddad W, Dhindsa S, Dandona P.

J Clin Endocrinol Metab. 2004 Jun;89(6):2728-35.

PMID:
15181049
11.

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.

Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group.

Arch Intern Med. 2004 May 24;164(10):1066-76.

PMID:
15159263
13.

Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial.

Nicklas BJ, Ambrosius W, Messier SP, Miller GD, Penninx BW, Loeser RF, Palla S, Bleecker E, Pahor M.

Am J Clin Nutr. 2004 Apr;79(4):544-51.

14.

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D.

JAMA. 2003 Apr 9;289(14):1799-804.

PMID:
12684358
15.

Association of hypoadiponectinemia with coronary artery disease in men.

Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y; Osaka CAD Study Group. Coronary artery disease.

Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):85-9.

16.

Adiponectin--its role in metabolism and beyond.

Stefan N, Stumvoll M.

Horm Metab Res. 2002 Sep;34(9):469-74. Review.

PMID:
12384822
17.

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.

Haffner SM, Greenberg AS, Weston WM, Chen H, Williams K, Freed MI.

Circulation. 2002 Aug 6;106(6):679-84.

18.

Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption.

Tamura T, Shirai T, Kosaka N, Ohmori K, Takafumi N.

Eur J Pharmacol. 2002 Jul 12;448(1):81-7.

PMID:
12126975
19.

Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.

Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD.

Diabetes Care. 2002 Mar;25(3):542-9. Erratum in: Diabetes Care 2002 May;25(5):947.

PMID:
11874944
20.

Diacerein suppresses the increase in plasma nitric oxide in rat adjuvant-induced arthritis.

Tamura T, Ohmori K.

Eur J Pharmacol. 2001 May 11;419(2-3):269-74.

PMID:
11426851
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk